Article
A comprehensive strategy to combat colon cancer targeting the adenomatous polyposis coli tumor suppressor gene.
Annals of the New York Academy of Sciences - 1 Nov 2005
Gerner Eugene W, Ignatenko Natalia A, Lance Peter, Hurley Laurence H
Abstract excerpt
Somatic cells in the majority of colorectal polyps and cancers contain mutations/deletions in the adenomatous polyposis coli (APC) tumor suppressor gene. APC is involved in normal intestinal development and acts to influence a variety of cellular processes. Loss of APC function leads to intestinal neoplasia in both mice and humans. APC influences expression of specific genes, including the c-Myc oncogene, which...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
